Connection

Hugh Myrick to Humans

Back to Details
This is a "connection" page, showing publications Hugh Myrick has written about Humans.
Hugh Myrick
Connection Strength
0.412
Humans
  1. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals. Psychopharmacology (Berl). 2014 Sep; 231(18):3799-807.
    View in: PubMed
    Score: 0.018
  2. Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics. Psychopharmacology (Berl). 2013 Jun; 227(4):627-37.
    View in: PubMed
    Score: 0.017
  3. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacology. 2013 Feb; 38(3):414-22.
    View in: PubMed
    Score: 0.016
  4. Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol. 2013 Jan; 18(1):121-33.
    View in: PubMed
    Score: 0.016
  5. Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach. Neuroimage. 2011 May 01; 56(1):61-8.
    View in: PubMed
    Score: 0.015
  6. The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. J Clin Psychopharmacol. 2010 Aug; 30(4):365-72.
    View in: PubMed
    Score: 0.014
  7. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009 Sep; 33(9):1582-8.
    View in: PubMed
    Score: 0.013
  8. Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry. 2008 Apr; 65(4):466-75.
    View in: PubMed
    Score: 0.012
  9. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcohol Clin Exp Res. 2007 Feb; 31(2):221-7.
    View in: PubMed
    Score: 0.011
  10. A retrospective chart review comparing tiagabine and benzodiazepines for the treatment of alcohol withdrawal. J Psychoactive Drugs. 2005 Dec; 37(4):409-14.
    View in: PubMed
    Score: 0.010
  11. Beliefs as a predictor of relapse in alcohol-dependent Turkish men. J Stud Alcohol. 2005 Nov; 66(6):848-51.
    View in: PubMed
    Score: 0.010
  12. Novel anticonvulsants in the treatment of alcoholism. Expert Opin Investig Drugs. 2005 Apr; 14(4):371-6.
    View in: PubMed
    Score: 0.010
  13. Safety and efficacy of GABAergic medications for treating alcoholism. Alcohol Clin Exp Res. 2005 Feb; 29(2):248-54.
    View in: PubMed
    Score: 0.010
  14. Telehealth service delivery for persons with alcoholism. J Telemed Telecare. 2005; 11(7):372-5.
    View in: PubMed
    Score: 0.009
  15. Diagnosis and treatment of co-occurring affective disorders and substance use disorders. Psychiatr Clin North Am. 2004 Dec; 27(4):649-59.
    View in: PubMed
    Score: 0.009
  16. Recent advances in the pharmacotherapy of alcoholism. Curr Psychiatry Rep. 2004 Oct; 6(5):332-8.
    View in: PubMed
    Score: 0.009
  17. Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues. Ann Clin Psychiatry. 2004 Apr-Jun; 16(2):101-9.
    View in: PubMed
    Score: 0.009
  18. Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology. 2004 Feb; 29(2):393-402.
    View in: PubMed
    Score: 0.009
  19. The use of divalproex in the treatment of addictive disorders. Psychopharmacol Bull. 2003; 37 Suppl 2:89-97.
    View in: PubMed
    Score: 0.008
  20. Divalproex loading in the treatment of cocaine dependence. J Psychoactive Drugs. 2001 Jul-Sep; 33(3):283-7.
    View in: PubMed
    Score: 0.007
  21. Gabapentin for misuse of homemade nicotine nasal spray. Am J Psychiatry. 2001 Mar; 158(3):498.
    View in: PubMed
    Score: 0.007
  22. Gabapentin in the treatment of cocaine dependence: a case series. J Clin Psychiatry. 2001 Jan; 62(1):19-23.
    View in: PubMed
    Score: 0.007
  23. New developments in the pharmacotherapy of alcohol dependence. Am J Addict. 2001; 10(s1):s3-s15.
    View in: PubMed
    Score: 0.007
  24. Divalproex in the treatment of alcohol withdrawal. Am J Drug Alcohol Abuse. 2000 Feb; 26(1):155-60.
    View in: PubMed
    Score: 0.007
  25. Gabapentin treatment of alcohol withdrawal. Am J Psychiatry. 1998 Nov; 155(11):1632.
    View in: PubMed
    Score: 0.006
  26. Priapism following trazodone overdose with cocaine use. Ann Clin Psychiatry. 1998 Jun; 10(2):81-3.
    View in: PubMed
    Score: 0.006
  27. Treatment of alcohol withdrawal. Alcohol Health Res World. 1998; 22(1):38-43.
    View in: PubMed
    Score: 0.006
  28. Randomized Controlled Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results From the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) Study. J Clin Psychiatry. 2017 Sep/Oct; 78(8):1075-1082.
    View in: PubMed
    Score: 0.006
  29. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology. 2017 Dec; 42(13):2640-2653.
    View in: PubMed
    Score: 0.006
  30. Social phobia in cocaine-dependent individuals. Am J Addict. 1997; 6(2):99-104.
    View in: PubMed
    Score: 0.005
  31. Suicide-specific Safety in the Inpatient Psychiatric Unit. Issues Ment Health Nurs. 2015 Mar; 36(3):190-9.
    View in: PubMed
    Score: 0.005
  32. Extended release naltrexone for alcohol use disorders: quasi-experimental effects on mortality and subsequent detoxification episodes. Alcohol Clin Exp Res. 2015 Jan; 39(1):79-83.
    View in: PubMed
    Score: 0.005
  33. Variation in SLC1A1 is related to combat-related posttraumatic stress disorder. J Anxiety Disord. 2014 Dec; 28(8):902-7.
    View in: PubMed
    Score: 0.005
  34. The relationship between years of cocaine use and brain activation to cocaine and response inhibition cues. Addiction. 2014 Dec; 109(12):2062-70.
    View in: PubMed
    Score: 0.005
  35. Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):44-9.
    View in: PubMed
    Score: 0.004
  36. Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):195-201.
    View in: PubMed
    Score: 0.004
  37. Health service utilization before and after evidence-based treatment for PTSD. Psychol Serv. 2013 Nov; 10(4):401-9.
    View in: PubMed
    Score: 0.004
  38. A pilot trial of neuropsychological evaluations conducted via telemedicine in the Veterans Health Administration. Telemed J E Health. 2012 Nov; 18(9):662-7.
    View in: PubMed
    Score: 0.004
  39. Computer simulation games as an adjunct for treatment in male veterans with alcohol use disorder. J Subst Abuse Treat. 2013 Mar; 44(3):316-22.
    View in: PubMed
    Score: 0.004
  40. Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes. Alcohol Clin Exp Res. 2012 Nov; 36(11):2000-7.
    View in: PubMed
    Score: 0.004
  41. Effects of divalproex on smoking cue reactivity and cessation outcomes among smokers achieving initial abstinence. Exp Clin Psychopharmacol. 2012 Aug; 20(4):293-301.
    View in: PubMed
    Score: 0.004
  42. Brain activation to cocaine cues and motivation/treatment status. Addict Biol. 2014 Mar; 19(2):240-9.
    View in: PubMed
    Score: 0.004
  43. Prolonged exposure therapy for combat-related posttraumatic stress disorder: comparing outcomes for veterans of different wars. Psychol Serv. 2012 Feb; 9(1):16-25.
    View in: PubMed
    Score: 0.004
  44. Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers. Addict Biol. 2011 Oct; 16(4):654-66.
    View in: PubMed
    Score: 0.004
  45. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence. Alcohol Clin Exp Res. 2011 Nov; 35(11):2030-8.
    View in: PubMed
    Score: 0.004
  46. Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry. 2011 Jul; 168(7):709-17.
    View in: PubMed
    Score: 0.004
  47. Prolonged exposure therapy for combat-related posttraumatic stress disorder: an examination of treatment effectiveness for veterans of the wars in Afghanistan and Iraq. J Anxiety Disord. 2011 Apr; 25(3):397-403.
    View in: PubMed
    Score: 0.004
  48. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009 Aug; 29(4):334-42.
    View in: PubMed
    Score: 0.003
  49. Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control. Alcohol Clin Exp Res. 2008 Nov; 32(11):1954-61.
    View in: PubMed
    Score: 0.003
  50. Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry. 2007 Jul; 164(7):1115-7.
    View in: PubMed
    Score: 0.003
  51. Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient. Am J Psychiatry. 2007 Jun; 164(6):979.
    View in: PubMed
    Score: 0.003
  52. Risk factors for delirium tremens: a retrospective chart review. Am J Addict. 2006 May-Jun; 15(3):213-9.
    View in: PubMed
    Score: 0.003
  53. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006 Jan-Feb; 15(1):105-10.
    View in: PubMed
    Score: 0.003
  54. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol. 2005 Aug; 25(4):349-57.
    View in: PubMed
    Score: 0.002
  55. Functional neuroanatomy of subcomponent cognitive processes involved in verbal working memory. Int J Neurosci. 2005 Jul; 115(7):1017-32.
    View in: PubMed
    Score: 0.002
  56. Health service use among persons with comorbid bipolar and substance use disorders. Psychiatr Serv. 2005 Apr; 56(4):475-80.
    View in: PubMed
    Score: 0.002
  57. Increased fasting plasma ghrelin levels during alcohol abstinence. Alcohol Alcohol. 2005 Jan-Feb; 40(1):76-9.
    View in: PubMed
    Score: 0.002
  58. The maximum-likelihood strategy for determining transcranial magnetic stimulation motor threshold, using parameter estimation by sequential testing is faster than conventional methods with similar precision. J ECT. 2004 Sep; 20(3):160-5.
    View in: PubMed
    Score: 0.002
  59. Complexity changes of the EEG induced by alcohol cue exposure in alcoholics and social drinkers. Alcohol Clin Exp Res. 2003 Dec; 27(12):1955-61.
    View in: PubMed
    Score: 0.002
  60. The use of divalproex in alcohol relapse prevention: a pilot study. Drug Alcohol Depend. 2002 Aug 01; 67(3):323-30.
    View in: PubMed
    Score: 0.002
  61. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med. 2002 May; 17(5):349-55.
    View in: PubMed
    Score: 0.002
  62. The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification. Am J Addict. 2002; 11(2):141-50.
    View in: PubMed
    Score: 0.002
  63. Clinical characteristics of under-reporters on urine drug screens in a cocaine treatment study. Am J Addict. 2002; 11(4):255-61.
    View in: PubMed
    Score: 0.002
  64. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict. 2001; 10(s1):s16-s23.
    View in: PubMed
    Score: 0.002
  65. Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol. 2000 Nov; 22(3):159-64.
    View in: PubMed
    Score: 0.002
  66. The relationship between substance use disorders, impulse control disorders, and pathological aggression. Am J Addict. 1998; 7(3):221-30.
    View in: PubMed
    Score: 0.001
  67. Gabapentin abuse in a cocaine user: implications for treatment? J Clin Psychopharmacol. 1997 Oct; 17(5):423-4.
    View in: PubMed
    Score: 0.001
  68. Clonidine dependence. J Clin Psychopharmacol. 1997 Apr; 17(2):137-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.